
JUBLPHARMAJubilant Pharmova Ltd.
Jubilant Pharmova Q2 FY27 Results: Consolidated Net Profit ₹31.00 Crore on Total Income of ₹2,384 Crore
Jubilant Pharmova (NSE: JUBLPHARMA) reported consolidated total income of ₹2,384 crore and net profit of ₹31 crore for the quarter ended 30 Sep 2026, and standalone total income of ₹69 crore and net profit of ₹8 crore, it said in a filing on 13 Nov 2026.
- Earnings
- pharmaceuticals